- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
James R. Brorson, MD, is an expert in the evaluation and treatment of stroke, transient ischemic attack and cerebrovascular disease. He diagnoses and treats patients with common and unusual types of cerebrovascular disease – including atherosclerosis, carotid artery narrowing, cardioembolic stroke, arterial dissection, intracranial aneurysm, cerebral venous sinus thrombosis, vascular malformations and moyamoya disease.
Working with colleagues in the sections of neurosurgery, vascular surgery, neuroradiology and cardiology, Dr. Brorson uses an interdisciplinary approach to decision making and planning therapies to prevent stroke and evaluating emerging treatments for cerebrovascular disease. He currently participates in clinical trials evaluating balloon angioplasty and stenting for carotid artery disease and percutaneous closure of patent foramen ovale (PFO) for stroke prevention.
Dr. Brorson's research efforts focus on understanding the mechanisms of neuronal damage pertinent to stroke and evaluating the best approaches to effective stroke prevention.
Working with colleagues in the sections of neurosurgery, vascular surgery, neuroradiology and cardiology, Dr. Brorson uses an interdisciplinary approach to decision making and planning therapies to prevent stroke and evaluating emerging treatments for cerebrovascular disease. He currently participates in clinical trials evaluating balloon angioplasty and stenting for carotid artery disease and percutaneous closure of patent foramen ovale (PFO) for stroke prevention.
Dr. Brorson's research efforts focus on understanding the mechanisms of neuronal damage pertinent to stroke and evaluating the best approaches to effective stroke prevention.
Specialties
- Neurology
- Vascular Neurology
Areas of Expertise
- Stroke
- Cerebrovascular Disease
- Cerebral Aneurysms (Brain Aneurysms )
- Cerebral Ischemia
- Ischemic Stroke
- Arteriovenous Malformations (AVM)
UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park5758 S. Maryland Ave., Chicago IL 606371-888-824-0200
Board Certifications
- Vascular Neurology
- Neurology
Practicing Since
- 1992
Languages Spoken
- English
Medical Education
- University of Chicago Pritzker School of Medicine
Internship
- University of Chicago medical internship
Residency
- University of Chicago Medicine; Hospitals of the University of Pennsylvania
Fellowship
- Research Fellowship in Neurology
Other Grad Education
- University of Pennsylvania
Memberships & Medical Societies
- American Academy of Neurology
- Stroke Council
- American Neurological Association
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.